Smith+Nephew announced the European commercial launch of its CARTIHEAL AGILI-C Cartilage Repair Implant across 12 key markets, expanding its Sports Medicine portfolio. The product is backed by clinical evidence showing superior knee outcomes and pain relief over five years. The global cartilage repair market is projected to grow from $5.98 billion in 2024 to $8.04 billion by 2030 at a 5.1% CAGR.

Smith+Nephew announced the commercial availability of its CARTIHEAL AGILI-C cartilage repair implant in Europe, following its 2024 US launch. The aragonite-based implant demonstrated clinical superiority over standard care in a multicenter randomized controlled trial, showing superior pain relief and functional gains over 5 years. The product will initially be available in 12 European countries.

Smith+Nephew announced the commercial launch of CARTIHEAL AGILI-C, an innovative cartilage repair implant, across Europe. The aragonite-based scaffold will be presented at the ICRS Summit in Portugal (October 8-10). A randomized controlled trial published in the American Journal of Sports Medicine demonstrated clinical superiority over standard surgical care, with patients showing improved pain relief and functional outcomes over 5 years. The implant will initially be available in 8 European countries with plans for further expansion.

Smith+Nephew (SNN) launched the EVOS PELVIC Plating System to expand its orthopedic trauma portfolio into pelvic and acetabular fracture management. The system features dedicated plates, cannulated screws, and specialized instruments designed to improve surgical efficiency. The global pelvic trauma market is projected to grow from $2.81 billion in 2025 to $4.79 billion by 2034 at a 6.1% CAGR, driven by increased high-energy fractures and wider adoption of surgical fixation protocols.

The AI in orthopedic surgery market is experiencing remarkable growth with a projected CAGR of 27.2% through 2030. Key drivers include rising musculoskeletal disorders, AI-assisted surgical planning, robotic surgical systems integration, and enhanced implant placement precision. North America leads the market, while Asia-Pacific and Europe show growing segments despite tariff-related challenges.

The global gauze bandage rolls market is valued at USD 1.96 billion in 2025 and is projected to reach USD 3.19 billion by 2035, growing at a CAGR of 4.97%. Growth is driven by rising surgical procedures, aging populations, chronic wound management, and technological advancements in antimicrobial and bioactive gauze products. Key market segments include cotton gauze (largest share), surgical wounds (dominant application), and hospitals (primary end-user), with Asia Pacific expected to show the fastest growth.

The global wound irrigation systems market is projected to grow from USD 307.87 million in 2025 to USD 430.05 million by 2035, with a CAGR of 3.55%. Growth is driven by rising chronic wound prevalence, increased surgical volumes, and innovations in pulsatile lavage systems. North America leads with 40% market share, while Asia Pacific shows the fastest growth at 4.7% CAGR. Manual systems currently dominate with 53% market share, though battery-operated systems are expected to grow fastest.

Smith+Nephew announced the US launch of its next generation LEAF Patient Monitoring System, a cloud-based platform designed to prevent hospital-acquired pressure injuries (HAPIs). The system uses wearable sensors to monitor patient mobility and improve turning protocol adherence. According to the company, the LEAF system monitors over 150,000 patients annually, reduces HAPI odds by up to 73%, and delivers up to $1.8 million in estimated savings per critical care facility.

Smith+Nephew is launching two new wound care products at the European Wound Management Association Conference in May 2026: ALLEVYN COMPLETE CARE Foam Dressing with enhanced exudate management and pressure ulcer prevention, and RENASYS EDGE Negative Pressure Wound Therapy System designed for simplicity and patient compliance. The launches address the significant healthcare challenge of chronic wounds affecting 14.9 million people in Europe.

The global wound cleanser products market is valued at USD 3.22 billion in 2025 and is projected to reach USD 5.17 billion by 2035, growing at a CAGR of 4.92%. Growth is driven by rising chronic wounds, surgical procedures, and demand for advanced antimicrobial cleansing solutions. The U.S. market is expected to grow from USD 0.99 billion to USD 1.49 billion during the same period. Saline-based cleansers dominate with 37.55% market share, while antimicrobial cleansers are expected to grow fastest at 6.18% CAGR.

The global tissue engineering market is projected to grow from USD 15.01 billion in 2026 to USD 27.59 billion by 2031, driven by advancements in regenerative medicine, biomaterials, and stem cell research. Key growth drivers include increasing demand for regenerative therapies, innovations in 3D bioprinting, rising prevalence of chronic diseases, and expanding applications in orthopedics, skin regeneration, and dental restoration. North America leads the market while Asia-Pacific emerges as a high-growth region.

The global surgical drill bits market was valued at USD 316 million in 2025 and is projected to reach USD 540 million by 2035, growing at a CAGR of 5.5%. Growth is driven by healthcare infrastructure development in emerging economies, increased surgical procedures, and rising demand for infection prevention measures. Hospitals are expected to dominate the market segment, while North America leads in market share and Asia-Pacific shows the highest growth rate.